13.03.2024 - Company remains focused on generating shareholder value by advancing portfolio and identifying attractive opportunities for strategic investments Increased ownership in Day Three Labs to a majority interest of 79% NEWARK, N.J., March 13, 2024 .
Company remains focused on generating shareholder value by advancing our portfolio and identifying attractive opportunities for strategic investmentsNEWARK, N.J., Dec. 14, 2023 Rafael Holdings,.
NEWARK, N.J., Oct. 30, 2023 (GLOBE NEWSWIRE) Rafael Holdings, Inc. (NYSE: RFL), today reported its financial results for the fourth quarter and full year of fiscal 2023 - the
Cyclo Therapeutics, Inc. , a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today.
Since the end of the third quarter, we made an initial $2.1 million investment in Cyclo Therapeutics, Inc. and have an agreement to increase our investment by $5 million NEWARK, N.J., June 13, 2023 . | June 13, 2023